Malarikova, D., Jorda, R., Kupcova, K., Senavova, J., Dolnikova, A., Pokorna, E., . . . Klener, P. (2024). Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion. BMC.
Chicago Style (17th ed.) CitationMalarikova, Diana, et al. Cyclin Dependent Kinase 4/6 Inhibitor Palbociclib Synergizes with BCL2 Inhibitor Venetoclax in Experimental Models of Mantle Cell Lymphoma Without RB1 Deletion. BMC, 2024.
MLA (9th ed.) CitationMalarikova, Diana, et al. Cyclin Dependent Kinase 4/6 Inhibitor Palbociclib Synergizes with BCL2 Inhibitor Venetoclax in Experimental Models of Mantle Cell Lymphoma Without RB1 Deletion. BMC, 2024.
Warning: These citations may not always be 100% accurate.